Without clinical trials we cannot expect to see any advancements in medicine; and to participate in one, patients need to be aware of ongoing trials. The National Cancer Institute (NCI) HINTS (Health Information Trends Survey, hints.cancer.gov)…
Patient recruitment has always been an Achilles heel in the success of clinical trials. As Stuart Horowitz, President of Institutions and Institutional Services, WIRB-Copernicus Group cites “The greatest challenge for multicenter clinical trials is the timely…
CAR T-Cell Immunotherapy has been named Advance of the Year in Annual ASCO Report. Cancer experts looking back over the past 12 months have highlighted adoptive immunotherapy with chimeric antigen receptor (CAR) T cells as the…
Communication between patients and research study staff can be challenging if both parties have different cultural and linguistic backgrounds. Specialized applications can potentially alleviate these problems and significantly contribute to an effective, improved care process when…
We participated and exhibited in three conferences this year – DIA, DPharm and AMIA. An awesome experience as always, our featured product this year was a no code DIY research study app making platform – called Appbakery….
We are excited to announce that last month our online patient-recruitment platform iConnect 2.0 went live with CenterWatch. Clinical trials professionals as well as patients trust CenterWatch to get any information related to clinical trials. It…
Two radically new gene based immunotherapies were approved by the FDA this year – Kymriah followed by Yescarta – in August and October, respectively. Approved in August 2017, before Novartis named the drug Kymriah (Tisagenlecleucel) – it…
